首页> 美国卫生研究院文献>Postgraduate Medical Journal >Adverse effects of captopril in hospital outpatients with hypertension.
【2h】

Adverse effects of captopril in hospital outpatients with hypertension.

机译:卡托普利在医院门诊高血压患者中的不良反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypertensive patients prescribed captopril while attending a hospital hypertension clinic were studied, to identify the benefits of the drug, its adverse effects and factors predisposing to them. One hundred and eighty two patients were followed for a mean of 18 months; 24 received captopril alone, and 158 combinations of captopril and other antihypertensive drugs, especially loop diuretics (91/158), or thiazide diuretics (57/158), or other vasodilators (57/158). The mean final dose of captopril was 67 mg/day. Blood pressure (BP) was effectively controlled in 73% of patients (mean fall in systolic BP 29 mmHg, CI 24 to 34, P less than or equal to 0.001; mean fall in diastolic BP 18 mmHg, CI 16 to 20, P less than or equal to 0.001). Blood urea and creatinine rose slightly in all patients (urea by 0.9 mmol/l [13%], CI 0.5-1.3, P less than or equal to 0.001 and creatinine by 9 mumols/l [8%], CI 4-13, P less than or equal to 0.001). Twenty six patients were withdrawn from captopril therapy: 6 because of poor control of their blood pressure, two because it was no longer necessary and 12 (7.7%) because of extrarenal adverse effects--10 for rashes, one each for gastric upset and impotence. Captopril was withdrawn in a further 6 patients, because of deteriorating renal function. Factors discriminating those at risk of renal dysfunction were high doses of captopril, concomitant high dose diuretic therapy and undiagnosed renovascular disease.
机译:研究了在医院高血压诊所开处方的卡托普利的高血压患者,以确定该药物的益处,不良反应和易患因素。一百八十二例患者平均随访18个月。 24例患者单独接受卡托普利治疗,并接受158剂卡托普利和其他降压药的联合治疗,尤其是loop利尿剂(91/158),噻嗪类利尿剂(57/158)或其他血管扩张药(57/158)。卡托普利的平均最终剂量为67毫克/天。有效控制了73%的患者的血压(BP)(收缩压平均下降29 mmHg,CI为24至34,P小于或等于0.001;舒张压平均下降为18 mmHg,CI 16至20,P较少大于或等于0.001)。所有患者的血尿素和肌酐略有上升(尿素上升0.9 mmol / l [13%],CI 0.5-1.3,P≤0.001,肌酐上升9μmol/ l [8%],CI 4-13, P小于或等于0.001)。二十六例患者退出卡托普利治疗:六例由于血压控制不佳,二例因为不再需要血压,十二例(7.7%)由于肾外不良反应-皮疹为-10,每例因胃部不适和阳imp而退缩。由于肾功能恶化,又有6例患者停用了卡托普利。区分那些有肾功能不全风险的因素是高剂量卡托普利,同时使用高剂量利尿剂和未确诊的肾血管疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号